Numantec

Goldman Sachs Alternatives Acquires Control of Italian Medtech Firm Numantec

Goldman Sachs Alternatives agreed to acquire Italian medtech firm Numantec from White Bridge Investment for approximately €700 million. Numantec manufactures healthcare products and drug-delivery devi